Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Study of Cord Blood-derived Cytokine-induced Killer Cells in Patients With Solid Tumor After Radical Resection

NCT01914263 is registered in ClinicalTrials.gov with Alliancells-PuRui Biocience Co., Ltd. as lead sponsor.

NCT NCT01914263
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01914263 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Study of Cord Blood-derived Cytokine-induced Killer Cells in Patients With Solid Tumor After Radical Resection
Lead sponsor
Alliancells-PuRui Biocience Co., Ltd.
Phase
Phase 1
Overall status
Unknown status
Start date
March 31, 2014
Completion date
June 30, 2016
Enrollment
40 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma, lung cancer, renal cell carcinoma